Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AJ Vaccines A/S
A/S
Active
CVR 37911143
Artillerivej 5, 2300
København S
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 9 years old
505 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
AJ Vaccines A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
584M
438M
292M
146M
0M
2021: 352M
352M
2021
2022: 421M (+20% vs 2021)
421M
+20%
2022
2023: 469M (+11% vs 2022)
469M
+11%
2023
2024: 413M (-12% vs 2023)
413M
-12%
2024
2025: 390M (-6% vs 2024)
390M
-6%
2025
EBITDA
DKK millions
0M
-238M
-477M
-715M
-954M
2021: -455M
-455M
2021
2022: -227M (+50% vs 2021)
-227M
+50%
2022
2023: -212M (+7% vs 2022)
-212M
+7%
2023
2024: -766M (-261% vs 2023)
-766M
-261%
2024
2025: -459M (+40% vs 2024)
-459M
+40%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
389.681
412.969
468.886
420.982
351.862
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-458.892
-766.299
-212.229
-226.829
-455.058
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-458.892
-766.299
-212.229
-226.829
-455.058
Net financials
-24.459
-41.073
-35.374
-45.846
-43.051
Profit before tax
-483.351
-807.117
-242.923
-268.810
-488.398
Tax
-0
-0
51
-721
-2.010
Net profit
-483.351
-807.117
-242.974
-268.090
-486.388
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
861.206
1.088.929
1.587.337
1.534.005
1.472.466
Equity
288.465
501.919
1.020.362
994.663
815.875
Long-term debt
319.721
311.485
326.662
258.373
283.456
Short-term debt
253.020
275.525
240.313
280.970
373.135
Total debt
572.741
587.010
566.975
539.343
656.591
Financial ratios
5-year trend
EBITDA margin
-117,8 %
This company
15,8 %
Market median
This company
Market median
846% below market
2021
2025
Equity ratio
33,5 %
This company
38,2 %
Market median
This company
Market median
12% below market
2021
2025
Return on equity
-167,6 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2021
2025
Net profit margin
-124,0 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,45×
This company
1,12×
Market median
This company
Market median
60% below market
2021
2025
Debt / equity
1,99×
This company
0,62×
Market median
This company
Market median
221% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on AJ Vaccines A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
